DR info

臨床試験数 : 4 / 薬物数 : 7 - (DrugBank : 1) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 44

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

ACZ885
   Novartis Pharma Services AG
      2010   Phase 2   EUCTR2010-020061-24-GB   Ireland;Italy;United Kingdom;
      2010   -   EUCTR2010-020061-24-IE   Ireland;Italy;United Kingdom;
ACZ885D
   NOVARTIS FARMA
      2010   -   EUCTR2010-020061-24-IT   Ireland;Italy;United Kingdom;
Canakinumab
   NOVARTIS FARMA
      2010   -   EUCTR2010-020061-24-IT   Ireland;Italy;United Kingdom;
Ilaris
   Novartis pharma AG
      -   Phase 3   EUCTR2017-001678-40-Outside-EU/EEA   Japan;
Recombinant human monoclonal antibody to human IL-1Beta of the IgG1/K class
   Novartis Pharma Services AG
      2010   Phase 2   EUCTR2010-020061-24-GB   Ireland;Italy;United Kingdom;
      2010   -   EUCTR2010-020061-24-IE   Ireland;Italy;United Kingdom;